Epinecidin-1 protects mice from LPS-induced endotoxemia and cecal ligation and puncture-induced polymicrobial sepsis,☆☆,☆☆☆

https://doi.org/10.1016/j.bbadis.2017.08.032Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Epinecidin-1 exhibits broad-spectrum antimicrobial and LPS neutralization activity.

  • Epinecidin-1 inhibits CLP-induced polymicrobial sepsis and LPS-induced endotoxemia.

  • Epinecidin-1 suppresses LPS binding to the cell surface and TLR4-mediated response.

  • Renal toxicity was not observed after epinecidin-1 treatment.

Abstract

The antimicrobial peptide, epinecidin-1 (Epi), was identified from Epinephelus coioides and may have clinical application for treating sepsis. Epi has been shown to ameliorate antibiotic-resistant bacteria-induced sepsis in mice, but further evaluation in mixed-flora models and a description of the protective mechanisms are essential to establish this peptide as a potential therapeutic. Therefore, we first tested the protective effects of Epi against polymicrobial sepsis-induced bactericidal infection, inflammation and lung injury that result from cecal ligation and puncture in mice. Furthermore, since lipopolysaccharide (LPS) is a key inducer of inflammation during bacterial infection and sepsis, we also tested the LPS-antagonizing activity and related mechanisms of Epi-mediated protection in mice with LPS-induced endotoxemia and LPS-treated Raw264.7 mouse macrophage cells. Epi rescued mice from both polymicrobial sepsis and endotoxemia after delayed administration and suppressed both lung and systemic inflammatory responses, while attenuating lung injury and diminishing bacterial load. In vitro studies revealed that Epi suppressed LPS-induced inflammatory cytokine production. Mechanistically, Epi disrupted the interaction between LPS and LPS binding protein, competed with LPS for binding on the cell surface, and inhibited Toll-like receptor 4 endocytosis, resulting in inhibition of LPS-induced reactive oxygen species/p38/Akt/NF-κB signaling and subsequent cytokine production. Overall, our results demonstrate that Epi is a promising therapeutic agent for endotoxemia and polymicrobial sepsis.

Keywords

Epinecidin-1
Sepsis
Endotoxemia
Macrophage
LPS
LPS binding protein

Cited by (0)

The authors declare no conflict of interest.

☆☆

This research was supported by the Marine Research Station (Jiaushi, Ilan), Institute of Cellular and Organismic Biology, Academia Sinica to Mr. Jyh-Yih Chen.

☆☆☆

This article is a Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease direct submission.